$OGEN
ORAGENICS INC

2019 Q1 Form 10-K Financial Statement

#000156459019010173 Filed on March 29, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $980.5K $1.031M $1.184M
YoY Change 22.56% 71.84% 27.29%
% of Gross Profit
Research & Development $2.414M $1.794M $1.581M
YoY Change 82.0% 118.72% 58.61%
% of Gross Profit
Depreciation & Amortization $12.87K $11.72K $8.390K
YoY Change 28.7% -41.4% -16.1%
% of Gross Profit
Operating Expenses $3.394M $2.825M $2.764M
YoY Change 59.98% 99.98% 43.86%
Operating Profit -$3.394M -$2.764M
YoY Change 59.98% 43.86%
Interest Expense $1.297K $68.59K $2.142K
YoY Change 54.96% -237.18% -97.98%
% of Operating Profit
Other Income/Expense, Net $68.49K $340.00 $6.506K
YoY Change 2868.92% -104.47%
Pretax Income -$3.326M -$2.756M -$2.758M
YoY Change 56.92% 88.74% 33.41%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.326M -$2.756M -$2.758M
YoY Change 56.92% 88.65% 33.41%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$108.9K -$211.3K -$231.0K
COMMON SHARES
Basic Shares Outstanding 46.11M 29.43M 11.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.35M $20.21M $13.81M
YoY Change 516.57% 227.53% 372.99%
Cash & Equivalents $29.35M $20.21M $13.81M
Short-Term Investments
Other Short-Term Assets $1.724M $1.725M $1.661M
YoY Change 139.46% 67.47% -23.82%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $31.07M $21.93M $15.47M
YoY Change 466.97% 204.92% 203.3%
LONG-TERM ASSETS
Property, Plant & Equipment $235.9K $116.3K $63.51K
YoY Change 1590.82% 436.85% 86.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $235.9K $116.3K $63.51K
YoY Change 1590.82% 436.85% 86.13%
TOTAL ASSETS
Total Short-Term Assets $31.07M $21.93M $15.47M
Total Long-Term Assets $235.9K $116.3K $63.51K
Total Assets $31.31M $22.05M $15.54M
YoY Change 469.83% 205.61% 202.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.975M $1.043M $1.367M
YoY Change 77.94% 27.24% -14.05%
Accrued Expenses $132.5K $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $77.53K $124.2K $190.4K
YoY Change 10.76% 55.26% 46.47%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.185M $1.168M $1.557M
YoY Change 85.3% 29.94% -9.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.185M $1.168M $1.557M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.185M $1.168M $1.557M
YoY Change 85.18% 29.73% -62.23%
SHAREHOLDERS EQUITY
Retained Earnings -$115.1M -$111.4M -$108.6M
YoY Change 11.14% 9.84% 8.68%
Common Stock $46.11K $29.43K $18.42K
YoY Change 788.99% 497.26% -62.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.12M $20.88M $13.98M
YoY Change
Total Liabilities & Shareholders Equity $31.31M $22.05M $15.54M
YoY Change 469.83% 205.61% 202.53%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$3.326M -$2.756M -$2.758M
YoY Change 56.92% 88.65% 33.41%
Depreciation, Depletion And Amortization $12.87K $11.72K $8.390K
YoY Change 28.7% -41.4% -16.1%
Cash From Operating Activities -$2.211M -$2.978M -$2.452M
YoY Change 61.76% 120.59% 82.98%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $13.80M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.35M 9.439M 12.39M
YoY Change -27367.12% 105.2% 468.23%
NET CHANGE
Cash From Operating Activities -2.211M -2.978M -2.452M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 11.35M 9.439M 12.39M
Net Change In Cash 9.141M 6.461M 9.936M
YoY Change -749.06% 98.81% 1082.8%
FREE CASH FLOW
Cash From Operating Activities -$2.211M -$2.978M -$2.452M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$2.978M -$2.452M
YoY Change 120.59% 82.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Entity Registrant Name
EntityRegistrantName
ORAGENICS INC
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001174940
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Trading Symbol
TradingSymbol
OGEN
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3505
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29433135
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29433135
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5971833
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3178662
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4022307
CY2018 us-gaap Operating Expenses
OperatingExpenses
9994140
CY2017 us-gaap Operating Expenses
OperatingExpenses
6718318
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-9994140
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-6718318
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
4928
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
86527
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126125976
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101402570
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111373608
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
10221
CY2018 us-gaap Interest Expense
InterestExpense
5786
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101400797
CY2017 us-gaap Interest Expense
InterestExpense
216328
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
20881983
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
6316309
CY2018 ogen Local Business Tax
LocalBusinessTax
1188
CY2017 ogen Local Business Tax
LocalBusinessTax
3098
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22049552
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7214831
CY2018Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46112303
CY2018Q2 dei Entity Public Float
EntityPublicFloat
2894038
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20208301
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6166143
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1724975
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1027029
CY2018Q4 us-gaap Assets Current
AssetsCurrent
21933276
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7193172
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116276
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21659
CY2018Q4 us-gaap Assets
Assets
22049552
CY2017Q4 us-gaap Assets
Assets
7214831
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1043356
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
818044
CY2018Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
124213
CY2017Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
80478
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1167569
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
898522
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
6100182
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
6309608
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
29433
CY2017Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
188727
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
446
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7271
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9914141
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
79999
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13207
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3539656
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4928335
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4928335
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6731525
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-9914141
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-6731525
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11326182
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6731525
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.87
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.37
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13039123
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4926275
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
2965723
CY2017 ogen Stockholders Equity Repayment Of Stock Subscription
StockholdersEquityRepaymentOfStockSubscription
30563
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
435216
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2062
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
123200
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
996038
CY2018 ogen Stock Issued During Period Value Registered Direct Offering
StockIssuedDuringPeriodValueRegisteredDirectOffering
1510327
CY2018 ogen Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
9505501
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
24320
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30110
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
65803
CY2018 us-gaap Restricted Stock Expense
RestrictedStockExpense
24320
CY2017 us-gaap Restricted Stock Expense
RestrictedStockExpense
123200
CY2018 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
996038
CY2017 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
437278
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
12000
CY2017 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
118237
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
453456
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
713896
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
225312
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
525777
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9079817
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6363853
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124727
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-124727
CY2018 us-gaap Interest Paid Net
InterestPaidNet
5786
CY2017 us-gaap Interest Paid Net
InterestPaidNet
4495
CY2018 us-gaap Notes Assumed1
NotesAssumed1
244490
CY2018 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-200755
CY2017 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-157946
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2400000
CY2018 ogen Net Proceeds From Issuance Of Common Stock Convertible Preferred Stock And Warrants
NetProceedsFromIssuanceOfCommonStockConvertiblePreferredStockAndWarrants
12431629
CY2018 ogen Proceeds From Issuance Of Common Stock For Warrant Exercise
ProceedsFromIssuanceOfCommonStockForWarrantExercise
9505501
CY2017 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
6176761
CY2017 ogen Proceeds From Payment Of Stock Subscription Receivable
ProceedsFromPaymentOfStockSubscriptionReceivable
30563
CY2018 ogen Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
1510327
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23246702
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8449378
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14042158
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2085525
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4080618
CY2017 us-gaap Notes Assumed1
NotesAssumed1
172047
CY2018 ogen Par Value Of Restricted Shares Issued
ParValueOfRestrictedSharesIssued
16
CY2017 ogen Par Value Of Restricted Shares Issued
ParValueOfRestrictedSharesIssued
160
CY2018 ogen Par Value Of Common Stock Issued
ParValueOfCommonStockIssued
25
CY2017 ogen Fair Market Value Of Warrants Issued
FairMarketValueOfWarrantsIssued
118237
CY2018 ogen Class Of Warrant Or Right Granted For Financial Advisory Services
ClassOfWarrantOrRightGrantedForFinancialAdvisoryServices
48387
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with US&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are stock-based compensation, valuation of warrants, and income tax valuation allowance.</p>
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.00
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2249594
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentrations</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains cash accounts in commercial banks, which may, at times, exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. As of December&#160;31, 2018, the uninsured portion of this balance was $19,958,301. As of December&#160;31, 2017, the uninsured portion of this balance was $5,916,143.</p>
CY2017Q4 ogen Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
5000
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
25105500
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
9684799
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4666667
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
14900000
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13000000
CY2018 ogen Cash And Cash Equivalents Maturity Date Description
CashAndCashEquivalentsMaturityDateDescription
Three months or less
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
Less than a 50%
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
19958301
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5916143
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1730881
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1606154
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1614605
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1584495
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
828706
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
618360
CY2018Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
39607
CY2017Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
39457
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
46775
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
45000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
123268
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
106722
CY2018Q4 ogen Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
5000
CY2017Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
120000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.10
CY2018Q1 ogen Stockholders Equity Reverse Stock Split Effective Date
StockholdersEquityReverseStockSplitEffectiveDate
2018-01-19
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4900000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2018Q1 ogen Fractional Shares From Reverse Stock Split Share
FractionalSharesFromReverseStockSplitShare
0
CY2018Q2 ogen Class Of Warrant Granted In Period
ClassOfWarrantGrantedInPeriod
900000
CY2018Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
900000
CY2018Q2 us-gaap Share Price
SharePrice
2.00
CY2018Q2 ogen Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P5Y
CY2018Q2 ogen Class Of Warrant Or Right Exercisable Period
ClassOfWarrantOrRightExercisablePeriod
P6M
CY2018Q3 ogen Class Of Warrant Granted In Period
ClassOfWarrantGrantedInPeriod
13800000
CY2018Q3 ogen Proceeds From Issuance Public Offering Net Of Expenses
ProceedsFromIssuancePublicOfferingNetOfExpenses
12400000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13800000
CY2018Q4 ogen Class Of Warrants Exercised
ClassOfWarrantsExercised
9505500
CY2017Q2 ogen Number Of Accredited Investors
NumberOfAccreditedInvestors
3
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13800000
CY2018Q3 ogen Beneficial Ownership Limitation Percentage
BeneficialOwnershipLimitationPercentage
0.0499
CY2018Q3 ogen Ownership Percentage Notification Period Requirement
OwnershipPercentageNotificationPeriodRequirement
P61D
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7371925
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1812133
CY2018 ogen Number Of Common Stock Outstanding If Warrants And Stock Options Exercised
NumberOfCommonStockOutstandingIfWarrantsAndStockOptionsExercised
40878896
CY2018Q4 ogen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
7371925
CY2018Q2 ogen Stock Issued During Period Registered Direct Offering Shares Issued
StockIssuedDuringPeriodRegisteredDirectOfferingSharesIssued
900000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.43
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0215
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.61
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.63
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0290
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0306
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
496448
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
162153
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7120
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105600
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
260633
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1500
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1553000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1034127
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.80
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.50
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.70
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.00
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
104.00
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.80
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23343153
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.89
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.57
CY2017 ogen Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
3.70
CY2018 ogen Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePrice
104.00
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
652885
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
445589
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
29946
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
34097
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2492392
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10055163
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2492392
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-10055163
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25628753
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
30051
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
26286
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
566367
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
334655
CY2018Q4 ogen Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
-808
CY2017Q4 ogen Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
27877
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26224363
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23731971
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26224363
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23731971
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2081970
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2288791
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-430770
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-244362
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2492392
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-10055163
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
12461939
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
121487
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
126377
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-101139
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 ogen Tax Cuts And Jobs Act Of2017 Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
10055163
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
102984000
CY2018 ogen Operating Loss Carryforwards Limitations On Use Of Federal Taxable Income Percentage
OperatingLossCarryforwardsLimitationsOnUseOfFederalTaxableIncomePercentage
0.80
CY2009Q2 ogen Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum
NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum
0.50
CY2013 ogen Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum
NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum
0.50
CY2009Q2 ogen Net Operating Loss Carryforwards Pre Change Annual Limitation
NetOperatingLossCarryforwardsPreChangeAnnualLimitation
417000
CY2013Q4 ogen Net Operating Loss Carryforwards Pre Change Annual Limitation
NetOperatingLossCarryforwardsPreChangeAnnualLimitation
3540000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
233944
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
140313
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1875337
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2015650
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2017 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
171804
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8784
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
180588
CY2018Q1 us-gaap Revenues
Revenues
0
CY2018Q2 us-gaap Revenues
Revenues
0
CY2018Q3 us-gaap Revenues
Revenues
0
CY2018Q4 us-gaap Revenues
Revenues
0
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
2121704
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
2283549
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2764341
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
2824546
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-2119397
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2281289
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-2757835
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-2755620
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2119397
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2281289
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4169876
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2755620
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.42
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.38
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.35
CY2018Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.09
CY2017Q1 us-gaap Revenues
Revenues
0
CY2017Q2 us-gaap Revenues
Revenues
0
CY2017Q3 us-gaap Revenues
Revenues
0
CY2017Q4 us-gaap Revenues
Revenues
0
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1987656
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
1396759
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
1921520
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
1412383
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-121
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
121
CY2017Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1982696
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1220866
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-2067230
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1460733
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.40
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.25
CY2017Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.42
CY2017Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.30
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2017Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2017Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00

Files In Submission

Name View Source Status
0001564590-19-010173-index-headers.html Edgar Link pending
0001564590-19-010173-index.html Edgar Link pending
0001564590-19-010173.txt Edgar Link pending
0001564590-19-010173-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2b02tc02pvu000001.jpg Edgar Link pending
ogen-10k_20181231.htm Edgar Link pending
ogen-20181231.xml Edgar Link completed
ogen-20181231.xsd Edgar Link pending
ogen-20181231_cal.xml Edgar Link unprocessable
ogen-20181231_def.xml Edgar Link unprocessable
ogen-20181231_lab.xml Edgar Link unprocessable
ogen-20181231_pre.xml Edgar Link unprocessable
ogen-ex231_10.htm Edgar Link pending
ogen-ex311_9.htm Edgar Link pending
ogen-ex312_8.htm Edgar Link pending
ogen-ex321_6.htm Edgar Link pending
ogen-ex322_7.htm Edgar Link pending
ogen-ex41_719.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending